EXPERIMENTAL STUDY
Soluble substances released from postischemic reperfused rat hearts reduce calcium transient and contractility by blocking the L-type calcium channel
Stephan B. Felix, MD*,
Verena Stangl, MD ,
Peter Pietsch, PhD ,
Peter Bramlage, MD ,
Alexander Staudt, MD*,
Sabine Bartel, PhD ,
Ernst-Georg Krause, MD ,
J.örn-Uwe Borschke, MD ,
Klaus-Dieter Wernecke, PhD||,
Gerrit Isenberg, MD and
Gert Baumann, MD
* Klinik für Innere Medizin B, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany
Medizinische Klinik und Poliklinik Charité, Kardiologie, Campus Mitte, Humboldt-Universität zu Berlin, Berlin, Germany
Max Delbrück Zentrum für molekulare Medizin, Berlin-Buch, Germany
Institut für Physiologie, Universität Halle, Halle, Germany
|| Institut für Medizinische Biometrie, Charité, Humboldt-Universtät zu Berlin, Berlin, Germany
Manuscript received December 6, 1999;
revised manuscript received August 22, 2000,
accepted October 2, 2000.
Reprint requests and correspondence: Dr. Stephan Felix, Klinik für Innere Medizin B, Ernst-Moritz-Arndt-Universität Greifswald, Friedrich Loeffler Strasse 23a, 17489 Greifswald, Germany felix{at}mail.uni-greifswald.de
OBJECTIVES
This study was designed to investigate the effects of cardiodepressant substances released from postischemic myocardial tissue on myocardial calcium-regulating pathways.
BACKGROUND
We have recently reported that new cardiodepressant substances are released from isolated hearts during reperfusion after myocardial ischemia.
METHODS
After 10 min of global ischemia, isolated rat hearts were reperfused, and the coronary effluent was collected for 30 s. We tested the effects of the postischemic coronary effluent on cell contraction, Ca2+ transients and Ca2+ currents of isolated rat cardiomyocytes by applying fluorescence microscopy and the whole-cell, voltage-clamp technique. Changes in intracellular phosphorylation mechanisms were studied by measuring tissue concentrations of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), as well as activities of cAMP-dependent protein kinase (cAMP-dPK) and protein kinase C (PKC).
RESULTS
The postischemic coronary effluent, diluted with experimental buffer, caused a concentration-dependent reduction of cell shortening and Ca2+ transient in the field-stimulated isolated cardiomyocytes of rats, as well as a reduction in peak L-type Ca2+ current in voltage-clamped cardiomyocytes. The current reduction resulted from reduced maximal conductancenot from changes in voltage- and time-dependent gating of the L-type Ca2+ channel. The postischemic coronary effluent modified neither the tissue concentrations of cAMP or cGMP nor the activities of cAMP-dPK and PKC. However, the effluent completely eliminated the activation of glycogen phosphorylase after beta-adrenergic stimulation.
CONCLUSIONS
Negative inotropic substances released from isolated postischemic hearts reduce Ca2+ transient and cell contraction through cAMP-independent and cGMP-independent blockage of L-type Ca2+ channels.
|
Abbreviations and Acronyms
| | BSA | = bovine serum albumin | | cAMP | = cyclic adenosine monophosphate | | cAMP-d PK | = cAMP-dependent protein kinase | | cGMP | = cyclic guanosine monophosphate | | DMSO | = dimethyl sulfoxide | | KHB | = Krebs-Henseleit buffer | | NIS | = negative inotropic substances | | pA | = picoampere | | pF | = picofarad | | PKC | = protein kinase C | | pS | = picosiemeus | | rfu | = relative fluorescence units | | SR | = sarcoplasmic reticulum |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Bien, A. Riad, C. A. Ritter, M. Gratz, F. Olshausen, D. Westermann, M. Grube, T. Krieg, S. Ciecholewski, S. B. Felix, et al.
The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy
Cancer Res.,
November 1, 2007;
67(21):
10428 - 10435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Birkenmeier, A. Staudt, W.-H. Schunck, I. Janke, C. Labitzke, T. Prange, C. Trimpert, T. Krieg, M. Landsberger, V. Stangl, et al.
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2148 - H2154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Felix, A. Staudt, M. Landsberger, Y. Grosse, V. Stangl, T. Spielhagen, G. Wallukat, K. D. Wernecke, G. Baumann, and K. Stangl
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
646 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stangl, G. Baumann, K. Stangl, and S. B Felix
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion
Cardiovasc Res,
January 1, 2002;
53(1):
12 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|